Development of the first commercially available recombinant human bone morphogenetic protein (rhBMP-2) as an autograft replacement for spinal fusion and ongoing R&D direction
2004 ◽
pp. 163-185
2004 ◽
Vol 86
(4)
◽
pp. 752-762
◽
2002 ◽
Vol 20
(4)
◽
pp. 740-746
◽
2013 ◽
Vol 158
(12)
◽
pp. 877
◽
2016 ◽
Vol 5
(4)
◽
pp. 145-152
◽